JP2538165B2 - 置換芳香族アミド成分を有するアミノカルボキシレ―ト配位子 - Google Patents

置換芳香族アミド成分を有するアミノカルボキシレ―ト配位子

Info

Publication number
JP2538165B2
JP2538165B2 JP4205097A JP20509792A JP2538165B2 JP 2538165 B2 JP2538165 B2 JP 2538165B2 JP 4205097 A JP4205097 A JP 4205097A JP 20509792 A JP20509792 A JP 20509792A JP 2538165 B2 JP2538165 B2 JP 2538165B2
Authority
JP
Japan
Prior art keywords
compound
alkyl
hydrogen
tetraazacyclododecane
hydroxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP4205097A
Other languages
English (en)
Japanese (ja)
Other versions
JPH05208920A (ja
Inventor
ラドハクリシュナ・ピライ
エドムンド・アール・マリネリ
ラマチャンドラン・エス・ランガナサン
マイケル・エフ・ツイードル
サン−イン・カン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BURATSUKO INTERN BV
Original Assignee
BURATSUKO INTERN BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BURATSUKO INTERN BV filed Critical BURATSUKO INTERN BV
Publication of JPH05208920A publication Critical patent/JPH05208920A/ja
Application granted granted Critical
Publication of JP2538165B2 publication Critical patent/JP2538165B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP4205097A 1991-08-01 1992-07-31 置換芳香族アミド成分を有するアミノカルボキシレ―ト配位子 Expired - Fee Related JP2538165B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73899891A 1991-08-01 1991-08-01
US738998 1991-08-01

Publications (2)

Publication Number Publication Date
JPH05208920A JPH05208920A (ja) 1993-08-20
JP2538165B2 true JP2538165B2 (ja) 1996-09-25

Family

ID=24970389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4205097A Expired - Fee Related JP2538165B2 (ja) 1991-08-01 1992-07-31 置換芳香族アミド成分を有するアミノカルボキシレ―ト配位子

Country Status (17)

Country Link
EP (1) EP0543482B1 (en:Method)
JP (1) JP2538165B2 (en:Method)
KR (1) KR930003911A (en:Method)
CN (1) CN1069027A (en:Method)
AT (1) ATE212861T1 (en:Method)
AU (1) AU2061592A (en:Method)
CA (1) CA2074867A1 (en:Method)
DE (1) DE69232408T2 (en:Method)
ES (1) ES2173862T3 (en:Method)
FI (1) FI923470L (en:Method)
HU (1) HUT62906A (en:Method)
IL (1) IL102570A0 (en:Method)
MX (1) MX9204434A (en:Method)
NO (1) NO305126B1 (en:Method)
PL (1) PL295490A1 (en:Method)
TW (1) TW213864B (en:Method)
ZA (1) ZA925521B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310535A (en) * 1992-04-24 1994-05-10 The Dow Chemical Company Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
WO1995027705A1 (en) * 1994-04-08 1995-10-19 Bracco International B.V. Aromatic amide compounds and metal chelates thereof
TW319763B (en:Method) 1995-02-01 1997-11-11 Epix Medical Inc
US6515113B2 (en) * 1999-02-18 2003-02-04 The Regents Of The University Of California Phthalamide lanthanide complexes for use as luminescent markers
FR2802928B1 (fr) * 1999-12-22 2003-01-31 Air Liquide Polyazacycloalcanes eventuellement greffes sur une matrice solide, complexes organometalliques les incorporant comme ligands. utilisation desdits composes a l'extraction de metaux lourds
EP1289571B1 (en) * 2000-05-12 2004-07-21 University Hospital Prochelators of radiometal labeled molecules
FR2827515B1 (fr) * 2001-07-20 2005-06-03 Oreal Composition moussante a base de silice et de polymere cationique
RU2425831C2 (ru) * 2005-12-02 2011-08-10 Джи-И Хелткер АС Мультимерные контрастные агенты для магнитного резонанса
BRPI0619198A2 (pt) * 2005-12-02 2011-09-20 Ge Healthcare As composto, composição, uso da composição, e, métodos para formação de imagem por rm e/ou de espectroscopia por rm, e para a preparação de compostos
EP2774611A4 (en) * 2011-10-06 2015-03-04 Ihi Corp MAGNETIC COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
CN103073667B (zh) * 2013-01-25 2016-05-11 南京大学 一种双伯胺基螯合树脂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03203282A (ja) * 1989-12-29 1991-09-04 Nec Kansai Ltd 半導体レーザダイオード
JP2776953B2 (ja) * 1990-04-10 1998-07-16 日本メジフィジックス株式会社 多官能性金属キレート化合物とその用途
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JP2807852B2 (ja) * 1991-07-18 1998-10-08 株式会社ミドリ十字 新規キレート化剤、該キレート化剤と金属原子との錯化合物及びそれを含む診断剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Ｊ．ＣＨＥＭ．ＳＯＣ．ＰＥＲＫＩＮＴＲＡＮＳ２ＮＯ．１（１９９１）Ｐ．８７−８９
ＭＵＣＬ．ＭＥＤ．ＢＩＯＬ．ＡＤＶ．ＰＲＯＣ．ＷＯＲＬＤＣＯＮＧＲ．３ＲＤＭＥＥＴＩＮＧＤＡＴＥ１９８２ＶＯＬＵＭＥ１Ｐ．２２７−２２９（１９８３）（ＣＨＥＭＩＣＡＬＡＢＳＴＲＡＣＴＳ９８：１７５６５１）

Also Published As

Publication number Publication date
AU2061592A (en) 1993-02-04
PL295490A1 (en) 1993-05-31
IL102570A0 (en) 1993-01-14
NO923038L (no) 1993-02-02
MX9204434A (es) 1994-06-30
NO305126B1 (no) 1999-04-06
DE69232408D1 (de) 2002-03-21
JPH05208920A (ja) 1993-08-20
NO923038D0 (no) 1992-07-31
TW213864B (en:Method) 1993-10-01
CA2074867A1 (en) 1993-02-02
ATE212861T1 (de) 2002-02-15
HU9202513D0 (en) 1992-10-28
ZA925521B (en) 1993-04-28
KR930003911A (ko) 1993-03-22
FI923470A7 (fi) 1993-02-02
EP0543482B1 (en) 2002-02-06
DE69232408T2 (de) 2002-09-19
EP0543482A1 (en) 1993-05-26
CN1069027A (zh) 1993-02-17
FI923470A0 (fi) 1992-07-31
FI923470L (fi) 1993-02-02
HUT62906A (en) 1993-06-28
ES2173862T3 (es) 2002-11-01

Similar Documents

Publication Publication Date Title
US7351389B2 (en) Aminocarboxylate ligands having substituted aromatic amide moieties
JP2604796B2 (ja) １０―置換―１，４，７―トリスカルボキシメチル―１，４，７，１０―テトラアザシクロドデカンおよび類縁体
JP3723219B2 (ja) カスケードポリマー錯体、その製造方法及びこれらを含有する医薬
EP0255471B1 (de) 1,4,7,10-Tetraazacyclododecan-Derivate
US5284647A (en) Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
JP3701678B2 (ja) カスケードポリマー錯体、その製造方法及びこれらを含有する医薬
JPH04288063A (ja) モノ‐ｎ‐置換１，４，７，１０‐テトラアザシクロドデカン誘導体、その製造法および該化合物を含有する医薬調剤
US6083479A (en) Contrast media for infarction and necrosis imaging
JPH05112567A (ja) ６員環を有する巨大環式テトラアザ化合物、その製法及びこれを含有する薬剤
JP2538165B2 (ja) 置換芳香族アミド成分を有するアミノカルボキシレ―ト配位子
US5575986A (en) Chelating agent, complex compound of said chelating agent and metallic atom, and diagnostic agent comprising same
JPH08510458A (ja) 沃素化された常磁性キレートおよびそれらの造影剤としての使用法
EP0717737B1 (en) Chelants as contrast enhancing agents
EP0565930A1 (en) Tetraazacyclododecane tetraacetic acid derivatives and the use thereof as diagnostic agents
DE3710730A1 (de) Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US6019959A (en) Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis
JP2004506026A (ja) 極性基を有するペルフルオロアルキル含有錯体、その製造方法およびその使用
NZ236267A (en) 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane
JPH04120065A (ja) １０−（２’−ヒドロキシ−３’−アルコキシ）−１，４，７−トリスカルボキシメチル−１，４，７，１０−テトラアザシクロドデカン
JP2001504843A (ja) 大環状金属錯体カルボン酸、その使用並びにその製造法
JP2538165C (en:Method)
JP3493156B2 (ja) ジポリキレート化剤
JPH0656802A (ja) テトラアザシクロドデカン誘導体およびその用途
US6166200A (en) Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees